Edwards Lifesciences (EW) Equity Ratio (2009 - 2026)

Edwards Lifesciences' Equity Ratio history runs 18 years deep, the most recent figure standing at 0.78 for Q1 2026.

• In Q1 2026, Equity Ratio fell 0.94% year-over-year to 0.78; the TTM figure through Mar 2026 stood at 0.78 (down 0.94% YoY), while the FY2025 annual figure was 0.75, down 2.08% from the prior year.
• Equity Ratio was 0.78 for Q1 2026 at Edwards Lifesciences, up from 0.75 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.79 in Q2 2025 to a low of 0.69 in Q1 2022.
• Historically, Equity Ratio has averaged 0.74 across 5 years, with a median of 0.74 in 2024.
• The sharpest annual moves came in 2022 and 2025: Equity Ratio climbed 7.5% in 2022, then retreated 2.08% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.7 in 2022, then gained by 2.49% to 0.72 in 2023, then rose by 7.41% to 0.77 in 2024, then slipped by 2.08% to 0.75 in 2025, then increased by 2.72% to 0.78 in 2026.
• The last three Equity Ratio figures came in at 0.78 (Q1 2026), 0.75 (Q4 2025), and 0.77 (Q3 2025), per Business Quant data.